Abstract
Acute heat loading is encountered in several everyday situations, during physical exercise or work in a hot climate are just 2 examples. Special forms of heat exposure include different types of steam baths and saunas. External heating induces changes in haemodynamics, body fluid volume and blood flow distribution, which in turn may affect the pharmacokinetics of a drug and the therapeutic response. Documentation of the effects of heat exposure on the pharmacokinetics of drugs in humans is very limited, but based on the documentation some general conclusions can be drawn.
The effects of external heating on absorption and elimination of those orally administered drugs which have been studied (e.g. midazolam, ephedrine, propranolol and tetracycline), have been minor. Systemic absorption of transdermally and subcutaneously administered drugs [insulin, nitroglycerin (glyceryl trinitrate) and nicotine] is in most cases enhanced by external heating, leading to higher plasma drug concentrations.
In general, pharmacokinetic interactions between heat exposure and drug therapy are rare and limited to special situations, in which local blood flow (for example, over the skin) is enhanced many-fold because of hyperthermia. When pharmacodynamics are concerned, in most cases the probability of interactions is low, but in the treatment of malignant tumours hyperthermia may potentiate cytotoxic effects of drugs without enhancement of myelosuppressive effects.
Similar content being viewed by others
References
Bull JMC. An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Res 1984; 44 Suppl.: 4853s–6s.
Vuori I. Sauna bather’s circulation. Ann Clin Res. 1988; 20: 249–56.
Leppäluoto J. Human thermoregulation in sauna. Ann Clin Res. 1988; 20: 240–3.
Rowell LB, Brengelmann GL, Murray JA. Cardiovascular responses to sustained high skin temperature in resting man. J Appl Physiol. 1969; 27(5): 673–80.
Shoenfeld Y, Sohar E, Ohry A, et al. Heat stress: comparison of short exposure to severe dry and wet heat in saunas. Arch Phys Med Rehabil. 1976; 57: 126–9.
Kukkonen-Harjula K, Oja P, Laustiola K, et al. Haemodynamic and hormonal responses to heat exposure in a Finnish sauna bath. Eur J Appl Physiol. 1989; 58: 543–50.
Kauppinen K. Sauna, shower and ice water immersion: physiological responses to brief exposures to heat, cool and cold. Part III: body temperatures. Arctic Med Res. 1989; 48: 75–86.
Harrison MH. Plasma volume changes during acute exposure to high environmental temperature. J Appl Physiol. 1974; 37(1): 38–42.
Kauppinen K. Sauna, shower and ice water immersion: physiological responses to brief exposures to heat, cool and cold. Part I: body fluid balance. Arctic Med Res. 1989; 48: 55–63.
Leppäluoto J, Arjamaa O, Vuolteenaho O, et al. Passive heat exposure leads to delayed increase in plasma levels of atrial natriuretic peptide in humans. J Appl Physiol. 1991; 71(2): 716–20.
Ahonen E, Nousiainen U. The sauna and body fluid balance. Ann Clin Res. 1988; 20: 257–61.
van Beaumont W, Underkofler S, van Beaumont S. Erythrocyte volume, plasma volume, and acid-base changes in exercise and heat dehydration. J Appl Physiol. 1981; 50(6): 1255–62.
Rowell LB. Cardiovascular adjustments to thermal stress. In: Shephard JT, Abbound FM, editors. Handbook of physiology. Section 2: the cardiovascular system. Vol 3: peripheral circulation and organ blood flow. Part 2. Chapter 27. Bethesda: American Physiological Society, 1983: 967–1023.
Rowell LB, Brengelmann GL, Blackmon JR, et al. Redistribution of blood flow during sustained high skin temperature in resting man. J Appl Physiol. 1970; 28(4): 415–20.
Rowell LB, Detry J-ML, Profant GR, et al. Splanchnic vasoconstriction in hyperthermic man: role of falling blood pressure. J Appl Physiol. 1971; 31(6): 864–9.
Swartz RD, Sidell FR, Cucinell SA. Effects of physical stress on the disposition of drugs eliminated by the liver in man. J Pharmacol Exp Ther. 1974; 188(1): 1–7.
Vanakoski J, Idänpään-Heikkilä JJ, Seppälä T. Exposure to high environmental temperature in the sauna does not change plasma indocyanine green (ICG) clearance in healthy subjects. Pharmacol Toxicol. 1996; 78: 94–8.
Kukkonen-Harjula K, Kauppinen K. How the sauna affects the endocrine system. Ann Clin Res. 1988; 20: 262–6.
Laatikainen T, Salminen K, Kohvakka A, et al. Response of plasma endorphins, prolactin and catecholamines in women to intense heat in a sauna. Eur J Appl Physiol. 1988; 57: 98–102.
Kukkonen-Harjula K, Oja P, Vuori I, et al. Cardiovascular effects of atenolol, scopolamine and their combination on healthy men in Finnish sauna baths. Eur J Appl Physiol. 1994; 69: 10–15.
Adlercreutz H, Kuoppasalmi K, Kosunen K, et al. Plasma cortisol, growth hormone (GH) and prolactin levels during exposure to intense heat. IRCS J Med Sci. 1976; 4: 546.
Leppäluoto J, Huttunen P, Hirvonen J, et al. Endocrine effects of repeated sauna bathing. Acta Physiol Scand. 1986; 128: 467–70.
Barkve TF, Langseth-Manrique K, Bredesen JE, et al. Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature. Am Heart J. 1986; 112(3): 537–41.
Danon A, Ben-Shimon S, Ben-Zvi Z. Effect of exercise and heat exposure on percutaneous absorption of methyl salicylate. Eur J Clin Pharmacol. 1986; 31: 49–52.
Formenti SC, Shrivastava PN, Sapozink M, et al. Abdominopelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology. Int J Radiat Oncol Biol Phys. 1996; 35(5): 993–1001.
Fujimura A, Sasaki M, Harada K, et al. Influences of bathing and hot weather on the pharmacokinetics of a new transdermal clonidine, M-5041T. J Clin Pharmacol. 1996; 36: 892–6.
Gerad H, Egorin MJ, Whitacre M, et al. Renal failure and platinum pharmacokinetics in three patients treated with cisdiamminedichloroplatinum(II) and whole-body hyperthermia. Cancer Chemother Pharmacol. 1983; 11: 162–6.
Koivisto VA. Sauna-induced acceleration in insulin absorption from subcutaneous injection site. BMJ. 1980; 280: 1411–3.
Koivisto VA. Influence of heat on insulin absorption: different effects on amorphous and soluble insulin. Acta Diabetol Lat. 1983; 20: 175–8.
Robins HI, Cohen JD, Schmitt CL, et al. Phase I clinical trial of carboplatin and 41.8°C whole-body hyperthermia in cancer patients. J Clin Oncol. 1993; 11(9): 1787–94.
Robins HI, Rushing D, Kurtz M, et al. Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients. J Clin Oncol. 1997; 15(1): 158–64.
Rönnemaa T, Koivisto VA. Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients. Diabetes Care. 1988; 11(10): 769–73.
Schlaeffer F, Engelberg I, Kaplanski J, et al. Effect of exercise and environmental heat on theophylline kinetics. Respiration. 1984; 45: 438–42.
Vanakoski J, Strömberg C, Seppälä T. Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women. Eur J Clin Pharmacol. 1993; 45: 377–81.
Vanakoski J, Seppälä T. Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers. Eur J Clin Pharmacol. 1995; 48: 133–7.
Vanakoski J, Idänpään-Heikkilä JJ, Olkkola K, et al. Effects of heat exposure in a Finnish sauna on the pharmacokinetics and metabolism of midazolam. Eur J Clin Pharmacol. 1996; 51: 335–8.
Vanakoski J, Seppälä T, Sievi E, et al. Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine. Clin Pharmacol Ther. 1996; 60(3): 308–15.
Vanakoski J, Seppälä T. Renal excretion of tetracycline is transiently decreased during short-term heat exposure. Int J Clin Pharmacol Ther. 1997; 35(5): 204–7.
Wiedemann GJ, d’Oleire F, Knop E, et al. Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients refractory sarcoma and malignant teratoma. Cancer Res. 1994; 54: 5346–50.
Neufer PD, Young AJ, Sawka MN. Gastric emptying during exercise: effects of heat stress and hypohydration. Eur J Appl Physiol. 1989; 58: 433–9.
Rehrer NJ, Beckers EJ, Brouns F, et al. Effects of dehydration on gastric emptying and gastrointestinal distress while running. Med Sci Sports Exerc. 1990; 22(6): 790–5.
Klemsdal TO, Gjesdal K, Bredesen J-E. Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin. Eur J Clin Pharmacol. 1992; 43: 625–8.
Brockmöller J, Roots I. Assessment of liver metabolic function. Clin Pharmacokinet. 1994; 27(3): 216–48.
Ballard BE. Pharmacokinetics and temperature. J Pharm Sci. 1974; 63(9): 1345–58.
Fabre G, Crevat-Pisano P, Dragna S, et al. Involvement of the macrolide antibiotic inducible cytochrome P-450 LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver. Biochem Pharmacol. 1988; 37(10): 1947–53.
Kronbach T, Mathys D, Umeno M, et al. Oxidation of midazolam by and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol. 1989; 36: 89–96.
Hasan J, Karvonen MJ, Piironen P. Special review: Part II. Physiological effects of extreme heat as studied in the Finnish ’sauna’ bath. Am J Phys Med. 1967; 46(2): 1226–46.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vanakoski, J., Seppälä, T. Heat Exposure and Drugs. Clin Pharmacokinet 34, 311–322 (1998). https://doi.org/10.2165/00003088-199834040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199834040-00004